Nature Publishing Group, publisher of Nature, and other science journals and reference works
Nature
my account e-alerts subscribe register
SEARCH JOURNAL     advanced search
Journal Home
Current Issue
AOP
Archive
Download PDF
References
Export citation
Export references
Send to a friend
More articles like this

Letters to Nature
Nature 355, 270 - 273 (16 January 1992); doi:10.1038/355270a0

Structural basis of latency in plasminogen activator inhibitor-1

James Mottonen*, Arne Strand*, Jindrich Symersky*, Robert M. Sweet, Dennis E. Danley, Kieran F. Geoghegan, Robert D. Gerard & Elizabeth J. Goldsmith*parallel

Departments of * Biochemistry and § Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75235-9050, USA
Department of Biology, Brookhaven National Laboratory, Upton, New York 11973, USA
Department of Molecular Genetics and Protein Chemistry, Central Research Division, Pfizer Inc., Eastern Point Road, Groton, Connecticut, 06340, USA
parallel To whom correspondence should be addressed.

HUMAN plasminogen activator inhibitor-1 (PAI-1)1,2 is the fast-acting inhibitor of tissue plasminogen activator and urokinase3 and is a member of the serpin family of protease inhibitors4. Serpins normally form complexes with their target proteases that dissociate very slowly as cleaved species and then fold into a highly stable inactive state5 in which the residues that flank the scissile bond (P1 and P1'; ref. 6) are separated by about 70 Å (refs 7–9). PAI-1 also spontaneously folds into a stable10 inactive state without cleavage; this state is termed 'latent' because inhibitory activity can be restored through denaturation and renaturation2,10. Here we report the structure of intact latent PAI-1 determined by single-crystal X-ray diffraction to 2.6 Å resolution. The three-dimensional structure reveals that residues on the N-terminal side of the primary recognition site are inserted as a central strand of the largest betasheet, in positions similar to the corresponding residues in the cleaved form of the serpin alpha1proteinase inhibitor (alpha1-PI)7. Residues C-terminal to the recognition site occupy positions on the surface of the molecule distinct from those of the corresponding residues in cleaved serpins7–9 or in the intact inactive serpin homologue, ovalbumin11, and its cleavage product, plakal-bumin12. The structure of latent PAI-1 is similar to one formed after cleavage in other serpins, and the stability of both latent PAI-1 and cleaved serpins may be derived from the same structural features13,14.

------------------

References
1. Ny, T., Sawdey, M., Lawrence, D., Millan, J. L. & Loskutoff, D. J. Proc. natn. Acad. Sci. U.S.A. 83, 6776−6780 (1986). | ChemPort |
2. Hekman, C. M. & Loskutoff, D. J. J. biol. Chem. 260, 11581−11587 (1985). | PubMed | ChemPort |
3. Andreasen, P. A., Georg, B., Lund, L. R., Riccio, A. & Stacey, S. N. Molec. cell. Endocr. 68, 1−19 (1990). | PubMed | ChemPort |
4. Huber, R. & Carrell, R. W. Biochemistry 28, 8951−8966 (1989). | Article | PubMed | ISI | ChemPort |
5. Bruch, M., Weiss, V. & Engel, J. J. biol. Chem. 263, 16626−16630 (1988). | PubMed | ISI | ChemPort |
6. Schechter, I. & Berger, A. Biochem. biophys. Res. Commun. 27, 157−162 (1967). | Article | PubMed | ISI | ChemPort |
7. Loebermann, H., Tokuoka, R., Deisenhofer, J. & Huber, R. J. molec. Biol. 177, 531−556 (1984). | Article | PubMed | ISI | ChemPort |
8. Baumann, U. et al. J. molec. Biol. 218, 595−606 (1991). | Article | PubMed | ISI | ChemPort |
9. Mourey, L. et al. Biochimie 72, 599−608 (1990). | Article | PubMed | ISI | ChemPort |
10. Katagiri, K., Okada, K., Hattori, H. & Yano, M. Eur. J. Biochem. 176, 81−87 (1988). | Article | PubMed | ChemPort |
11. Stein, P. E. et al. Nature 347, 99−102 (1990). | Article | PubMed | ISI | ChemPort |
12. Wright, H. T., Qian, H. X. & Huber, R. J. molec. Biol. 213, 513−528 (1990). | PubMed | ISI | ChemPort |
13. Munch, M., Heegaard, C., Jensen, P. H. & Andreasen, P. A. EMBO J. (in the press).
14. Carrell, R. W., Evans, D. L. & Stein, P. E. Nature 353, 576−578 (1991). | Article | PubMed | ISI | ChemPort |
15. Papamokos, E. et al. J. molec. Biol. 158, 515−537 (1982). | Article | PubMed | ChemPort |
16. Madison, E. L., Goldsmith, E. J., Gerard, R., Gething, M. J. & Sambrook, J. F. Nature 339, 721−723 (1989). | Article | PubMed | ISI | ChemPort |
17. Madison, E. L. et al. Proc. natn. Acad. Sci. U.S.A. 87, 3530−3533 (1990). | ChemPort |
18. Madison, E. L., Goldsmith, E. J., Gething, M. J., Sambrook, J. F. & Gerard, R. D. J. biol. Chem. 265, 21423−21426 (1990). | PubMed | ISI | ChemPort |
19. Kress, L. F., Kurecki, T., Chan, S. K. & Laskowski, M. J. biol. Chem. 254, 5317−5320 (1979). | PubMed | ISI | ChemPort |
20. Schulze, A. J. et al. Eur. J. Biochem. 194, 51−56 (1990). | Article | PubMed | ISI | ChemPort |
21. Skriver, K. et al. J. biol. Chem. 266, 9216−9221 (1991). | PubMed | ISI | ChemPort |
22. Lawrence, D. A., Strandberg, L., Ericson, J. & Ny, T. J. biol. Chem. 265, 20293−20301 (1990). | PubMed | ISI | ChemPort |
23. Wiman, B., Almquist, Å., Sigurdardottir, O. & Lindahl, T. FEBS Lett. 242, 125−128 (1988). | Article | PubMed | ChemPort |
24. Carrell, R. W. & Owen, M. C. Nature 317, 730−732 (1985). | Article | PubMed | ISI | ChemPort |
25. Jones, T. A. & Kjeldgaard, M. O. Version 5.4 (Dept Molec. Biol., Univ. Uppsala, Sweden, 1991).
26. Franke, A. E. et al. Biochim. biophys. Acta 1037, 16−23 (1990). | Article | PubMed | ISI | ChemPort |
27. Goldsmith, E. J. et al. Proteins 9, 225−227 (1991). | Article | PubMed | ChemPort |
28. Howard, A. J., Nielsen, C. & Xuong, N.-H. Meth. Enzym. 114a, 452−472 (1985).
29. Crowther, R. A. Acta crystallogr. B25, 2571−2580 (1969). | ChemPort |
30. Crowther, R. A. & Blow, D. M. Acta crystallogr. 23, 544−548 (1967). | Article | ISI | ChemPort |
31. Fitzgerald, P. F. J. appl. Crystallogr. 21, 273−278 (1988). | Article | ISI | ChemPort |
32. Brünger, A. T., Kuriyan, J. & Karplus, M. Science 235, 458−460 (1987). | ISI |
33. Carson, M. & Bugg, C. E. J. molec. Graph. 4, 121−122 (1986). | ChemPort |



© 1992 Nature Publishing Group
Privacy Policy